DE602005025767D1 - Orale tedisamilformulierungen mit magenretentionseigenschaften und verzögerter freisetzung - Google Patents
Orale tedisamilformulierungen mit magenretentionseigenschaften und verzögerter freisetzungInfo
- Publication number
- DE602005025767D1 DE602005025767D1 DE602005025767T DE602005025767T DE602005025767D1 DE 602005025767 D1 DE602005025767 D1 DE 602005025767D1 DE 602005025767 T DE602005025767 T DE 602005025767T DE 602005025767 T DE602005025767 T DE 602005025767T DE 602005025767 D1 DE602005025767 D1 DE 602005025767D1
- Authority
- DE
- Germany
- Prior art keywords
- tedisamil
- retention properties
- formulations
- oral
- delayed release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58279804P | 2004-06-28 | 2004-06-28 | |
EP04102987 | 2004-06-28 | ||
PCT/EP2005/052984 WO2006000583A2 (en) | 2004-06-28 | 2005-06-27 | Oral sustained release formulation of tedisamil with gastric retention properties |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005025767D1 true DE602005025767D1 (de) | 2011-02-17 |
Family
ID=35782155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005025767T Active DE602005025767D1 (de) | 2004-06-28 | 2005-06-27 | Orale tedisamilformulierungen mit magenretentionseigenschaften und verzögerter freisetzung |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1763338B1 (de) |
JP (1) | JP2008504250A (de) |
KR (1) | KR20070028598A (de) |
AT (1) | ATE493974T1 (de) |
AU (1) | AU2005256653B2 (de) |
CA (1) | CA2569919A1 (de) |
DE (1) | DE602005025767D1 (de) |
IL (1) | IL179859A0 (de) |
MX (1) | MXPA06015095A (de) |
NO (1) | NO20070522L (de) |
RU (1) | RU2385724C2 (de) |
WO (1) | WO2006000583A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
KR101050015B1 (ko) * | 2007-09-21 | 2011-07-19 | 동아제약주식회사 | 위체류약물전달시스템을 이용한 애엽 추출물의 약학조성물및 이를 이용한 서방성 경구용 제제 |
WO2009064458A2 (en) | 2007-11-13 | 2009-05-22 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
WO2009157711A2 (ko) * | 2008-06-24 | 2009-12-30 | Park Eun-Seok | 위장체류형 다공성 정제 및 그의 제조 방법 |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
AU2010286354A1 (en) * | 2009-08-31 | 2012-04-19 | Depomed, Inc. | Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen |
EP2468264A1 (de) * | 2010-12-27 | 2012-06-27 | Laboratorios Liconsa, S.A. | Orale pharmazeutische Tablette zur gesteuerten Abgabe von Mesalazin und Verfahren zu deren Erhalt |
CN103393620B (zh) * | 2013-08-05 | 2016-02-03 | 青岛市中心医院 | 一种阿折地平胶囊剂及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ524641A (en) * | 2000-09-29 | 2004-09-24 | Solvay Pharmaceuticals B | A pharmaceutical hydrophilic gel forming matrix formulation having prolonged release which is ion strength independent |
-
2005
- 2005-06-27 MX MXPA06015095A patent/MXPA06015095A/es unknown
- 2005-06-27 CA CA002569919A patent/CA2569919A1/en not_active Abandoned
- 2005-06-27 KR KR1020077002141A patent/KR20070028598A/ko not_active Application Discontinuation
- 2005-06-27 EP EP05785782A patent/EP1763338B1/de active Active
- 2005-06-27 DE DE602005025767T patent/DE602005025767D1/de active Active
- 2005-06-27 RU RU2007103195/15A patent/RU2385724C2/ru not_active IP Right Cessation
- 2005-06-27 AU AU2005256653A patent/AU2005256653B2/en not_active Ceased
- 2005-06-27 WO PCT/EP2005/052984 patent/WO2006000583A2/en active Application Filing
- 2005-06-27 JP JP2007517305A patent/JP2008504250A/ja not_active Withdrawn
- 2005-06-27 AT AT05785782T patent/ATE493974T1/de not_active IP Right Cessation
-
2006
- 2006-12-05 IL IL179859A patent/IL179859A0/en unknown
-
2007
- 2007-01-26 NO NO20070522A patent/NO20070522L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1763338A2 (de) | 2007-03-21 |
ATE493974T1 (de) | 2011-01-15 |
JP2008504250A (ja) | 2008-02-14 |
AU2005256653B2 (en) | 2010-10-14 |
IL179859A0 (en) | 2007-05-15 |
CA2569919A1 (en) | 2006-01-05 |
AU2005256653A1 (en) | 2006-01-05 |
WO2006000583A3 (en) | 2006-10-12 |
MXPA06015095A (es) | 2007-07-17 |
RU2007103195A (ru) | 2008-08-10 |
KR20070028598A (ko) | 2007-03-12 |
WO2006000583A2 (en) | 2006-01-05 |
EP1763338B1 (de) | 2011-01-05 |
RU2385724C2 (ru) | 2010-04-10 |
NO20070522L (no) | 2007-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005025767D1 (de) | Orale tedisamilformulierungen mit magenretentionseigenschaften und verzögerter freisetzung | |
IL259851A (en) | Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders | |
UA94390C2 (ru) | Применение производных индолинонов, предназначенных для лечения или предупреждения идиопатического фиброза легких | |
CY1119007T1 (el) | Συνθεσεις και μεθοδοι αγωγης πνευμονικης υπερτασης | |
EA201190145A1 (ru) | Фармацевтические композиции, содержащие основание прасугреля или его фармацевтически приемлемые соли присоединения кислоты, и способы их приготовления | |
WO2004030611A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
ECSP088560A (es) | Formulacion de liberacion sostenida que comprende octreotida y dos o mas polimeros de polilactido-co-glicolido | |
ATE437679T1 (de) | Wässrige antitranspirant formulierung | |
WO2007143557A3 (en) | Compounds and methods for treating mammalian gastrointestinal parasitic infections | |
NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
MXPA05010000A (es) | Derivados de p-diaminobenceno substituidos. | |
EA200702282A1 (ru) | Комбинация феррохина и производного артемизинина для лечения малярии | |
ATE392889T1 (de) | Orale antimikrobielle pharmazeutische zusammensetzungen | |
WO2009120389A8 (en) | Oral and injectable formulations of tetracycline compounds | |
TR201009394A2 (tr) | Geliştirilmiş montelukast formülasyonları. | |
EA200702201A1 (ru) | Рофлумиласт для лечения лёгочной гипертензии | |
WO2014119985A3 (es) | Composición farmacéutica con un inhibidor selectivo de la enzima fosfodiesterasa en forma de gel oral | |
DE602005023742D1 (de) | Formulierung von 3-amino-8-(1-piperazinyl)-2h-1benzopyran-2-on mit verzögerter freisetzung | |
EA200801890A1 (ru) | Средство для лечения шума в ушах | |
TW200603793A (en) | Oral sustained release formulation of tedisamil with gastric retention properties | |
NO20064196L (no) | Utvortes preparat for behandling av smertefulle hudskader | |
TR201001862A1 (tr) | Kontrollü salım gerçekleştiren pramipeksol formülasyonları. | |
MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
TR201901012T4 (tr) | Arteriosklerozun tedavisinde nor-safra asitlerinin kullanımı. | |
CY1114028T1 (el) | Φαρμακευτικες συνθεσεις για τη θεραπεια των ακροχορδωνων |